Significantly elevated levels of circulating α2AP have been identified as a key component in the pathophysiology of pulmonary arterial hypertension (PAH), contributing to poorer outcomes and higher mortality (45, 46). The gene discussed is SERPINF2; the disease is pulmonary arterial hypertension.